{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=141474", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=141474", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=141474&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=141474", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=141474", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=141474", "items" : [{"_about" : "http://data.parliament.uk/resources/1584867", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1584867/answer", "answerText" : {"_value" : "

The Department has not made an assessment of the effectiveness of Auditory Verbal Therapy (AVT) for deaf children or the adequacy of the accessibility of AVT for deaf children on the National Health Service.<\/p>

Commissioning of hearing services takes place at a local level based on the needs of the local population. The Secretary of State has, therefore, no plans to hold discussions with Auditory Verbal UK on NHS funding for early intervention programmes for deaf children.<\/p>

In 2019, NHS England, with input from the National Deaf Children\u2019s Society, produced a guide for commissioners and health and local authority providers who support children and young people with hearing loss, this can be found at the following link:<\/p>

https://www.england.nhs.uk/wp-content/uploads/2019/11/what-works-chswg-guide.pdf<\/a><\/p>

The guide provides practical advice to organisations, commissioners and providers on how they can ensure children with hearing loss receive the support they need, so that they can lead successful, fulfilling and independent lives.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "answeringMemberConstituency" : {"_value" : "Harborough"} , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"} , "dateOfAnswer" : {"_value" : "2023-02-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "141475"} , {"_value" : "141476"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-14T13:13:59.987Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-02-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Speech and Language Therapy: Children"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of Auditory Verbal Therapy for deaf children.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4491", "label" : {"_value" : "Biography information for Vicky Foxcroft"} } , "tablingMemberConstituency" : {"_value" : "Lewisham, Deptford"} , "tablingMemberPrinted" : [{"_value" : "Vicky Foxcroft"} ], "uin" : "141474"} , {"_about" : "http://data.parliament.uk/resources/1279278", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1279278/answer", "answerText" : {"_value" : "

The Government invested over £300 million in 2020 to secure and scale-up the UK\u2019s manufacturing capabilities to respond to this pandemic, including:<\/p>

- £127 million towards the Cell and Gene Therapy Catapult Braintree in Essex;<\/p>

- £93 million to accelerate the completion and expanded role of the Vaccine Manufacturing Innovation Centre in Oxfordshire;<\/p>

- £4.7 million for skills training through the Advanced Therapies Skills Training Network, which will be delivered through both virtual and physical centres;<\/p>

- £8.75 million for the set-up of the rapid deployment facility at Oxford Biomedica in Oxfordshire; and<\/p>

- £65.5 million for the manufacture of the University of Oxford / AstraZeneca vaccine.<\/p>

<\/p>

In addition to the above, we have also funded the fill and finish of vaccines through a contract with Wockhardt in Wrexham, North Wales, as well as the expansion of the Valneva factory in Livingston, Scotland. However, we are not able to give further details on these two developments owing to commercial confidentiality.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-01-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-01-26T16:15:42.617Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answers of 19 January 2021 to Questions 137942 and 137941, if he will provide a breakdown of the £300 million invested in securing and scaling up UK manufacturing capacity by (a) type of capacity, (b) geographical location and (c) the date that investment was delivered.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"} } , "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"} , "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"} ], "uin" : "141474"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }